...
首页> 外文期刊>Indian medical journal >Variceal bleeding in Liver Cirrhosis : Bacterial infection and efficacy of intravenous and pre-oral application of antibiotics-a randomized trial
【24h】

Variceal bleeding in Liver Cirrhosis : Bacterial infection and efficacy of intravenous and pre-oral application of antibiotics-a randomized trial

机译:肝硬化静脉曲张破裂出血:细菌感染以及抗生素静脉内和口服应用的有效性-一项随机试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objective : To determine the prevalence of bacterial infection in patients admitted to hospital with variceal bleeding in liver cirrhosis in comparison with patients with liver cirrhosis admitted because of another reason. The effect of orally and intravenous administered antibiotic.Method : Bacteriological investigation of blood culture, urine culture, throat smear, perianal smear and ascites (poly-morphonuclear count as well in ascites) was made in 44 cirrhotic patients admitted to hospital with variGeal bleeding and 46 cirrhotic patients admitted because of another reason. Bleeders were treated endoscopically (band ligation) and pharmacologically (injection octriotide 250 microgram bolus and followed by 25 to 50 microgram per hour for 5 days) and were randomly allocated to the treatment with oral norfloxacin (24 patients) or intravenous ampicillin/ sulbactam (20 patients). Early and late mortalities were evaluated.Results : The incidence of infection was high in both groups (61.3% bleeders vs. 54.3% control), but bleeding patients more often had positive blood culture (13.6% vs. 6.5%) and statistically significantly more positive findings in the throat smears (36.5% vs. 17.3%, P=0.04), which gives the evidence of increased pathological colonization in these patients. No difference in survival was seen in patients with per-oral or intravenous administration of antibiotics.Conclusion : Bacterial infection was demonstrated in a high percentage in patients with liver cirrhosis admitted to hospital. The administration of antibiotics is indicated in these patients. Intravenous application is probably of the same efficacy as per-oral administration.
机译:目的:确定因肝硬化静脉曲张破裂出血而住院的患者与因其他原因而住院的肝硬化患者之间细菌感染的患病率。方法:对44例因肝硬化和静脉曲张破裂出血住院的肝硬化患者进行细菌学检查,包括血液培养,尿培养,咽喉涂片,肛周涂片和腹水(腹水中也有多形核细胞计数)。 46位肝硬化患者因其他原因入院。内窥镜检查(带结扎)和药理治疗胆囊出血(注射奥曲肽250微克推注,然后每小时25至50微克,持续5天),随机分配口服诺氟沙星治疗(24例)或静脉使用氨苄西林/舒巴坦治疗(20耐心)。结果:两组的感染发生率均很高(出血率为61.3%,对照组为54.3%),但是出血患者的血液培养阳性率更高(13.6%vs. 6.5%),统计学上显着更高喉部涂片检查阳性(36.5%vs. 17.3%,P = 0.04),这提供了这些患者病理定植增加的证据。经口服或静脉内使用抗生素的患者生存率无差异。结论:住院肝硬化患者中细菌感染的比例很高。这些患者需要使用抗生素。静脉内施用可能与经口施用具有相同的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号